BIOMAT Database Logo BIOMAT Database Logo

Purified chick embryo cell rabies vaccine. 1986

C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Adverse reactions to purified chick embryo cell rabies vaccine.
November 1994, Vaccine,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine.
March 1994, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine.
November 1992, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Failure of rabies postexposure treatment with purified chick embryo cell (PCEC) vaccine.
October 1989, Vaccine,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Purified chick embryo cell (PCEC) rabies vaccine for human use. Laboratory data.
November 1984, Behring Institute Mitteilungen,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Purified chick embryo cell (PCEC) rabies vaccine for human use: clinical trials.
November 1984, Behring Institute Mitteilungen,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).
January 2008, Human vaccines,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Immune response to purified chick embryo cell culture rabies vaccine manufactured in India.
March 1992, The Indian journal of medical research,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).
July 2013, Human vaccines & immunotherapeutics,
C Wasi, and P Chaiprasithikul, and L Chavanich, and P Puthavathana, and P Thongcharoen, and M Trishanananda
Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
August 2007, The Journal of pediatrics,
Copied contents to your clipboard!